DEDavid E. RootSep 1, 2026New paperautoPaperFANCM is required for the PAX3::FOXO1-driven oncogenic program in rhabdomyosarcomaCell Reports · 2026 · Christopher D Delaney, Min Lu, Seth P Zimmerman et al.4